Topical and Transdermal Drug Delivery 2011
DOI: 10.1002/9781118140505.ch5
|View full text |Cite
|
Sign up to set email alerts
|

In VitroSkin Permeation Methodology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
21
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(22 citation statements)
references
References 88 publications
1
21
0
Order By: Relevance
“…The phosphate buffer solution was chosen for maintenance of the physiological conditions. 37 1%SLS was added to maintain sink conditions. The rotation was adjusted at 50 rpm and the temperature of the medium was kept at 37±0.5 °C.…”
Section: Eementioning
confidence: 99%
“…The phosphate buffer solution was chosen for maintenance of the physiological conditions. 37 1%SLS was added to maintain sink conditions. The rotation was adjusted at 50 rpm and the temperature of the medium was kept at 37±0.5 °C.…”
Section: Eementioning
confidence: 99%
“…Considerable individual variation in the absorption of methimazole was observed between the 6 cats (Figs & ). High intra‐ and interindividual variability is expected in in vitro transdermal trials and reflects the variability in the cat population (Finnin et al ., ). Individual variation between cats was also seen in a previous, in vitro study of methimazole in two transdermal formulations.…”
mentioning
confidence: 97%
“…High intra- and inter-individual variability is expected in in vitro transdermal trials. 29 In the current study, each cat received the same dose to the right and left ear, and the left and right ears were compared to determine inter-individual differences. A difference in methimazole absorption was found between the left and right ears, and there was also considerable variability between subjects for the methimazole concentrations remaining in the ear (Figure 3).…”
Section: Discussionmentioning
confidence: 99%